CKPT
Price
$2.08
Change
+$0.04 (+1.96%)
Updated
Mar 28, 1:56 PM EST
LYRA
Price
$6.45
Change
-$0.08 (-1.23%)
Updated
Mar 28, 2:12 PM EST
40 days until earnings call
Ad is loading...

Analysis and predictions CKPT vs LYRA

Header iconCKPT vs LYRA Comparison
Open Charts CKPT vs LYRABanner chart's image
Checkpoint Therapeutics
Price$2.08
Change+$0.04 (+1.96%)
Volume$236
CapitalizationN/A
Lyra Therapeutics
Price$6.45
Change-$0.08 (-1.23%)
Volume$1.73K
CapitalizationN/A
View a ticker or compare two or three
CKPT vs LYRA Comparison Chart

Loading...

CKPTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
LYRADaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CKPT vs. LYRA commentary
Mar 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CKPT is a Hold and LYRA is a Hold.

COMPARISON
Comparison
Mar 28, 2024
Stock price -- (CKPT: $2.04 vs. LYRA: $6.53)
Brand notoriety: CKPT and LYRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CKPT: 46% vs. LYRA: 274%
Market capitalization -- CKPT: $72.62M vs. LYRA: $390.12M
CKPT [@Biotechnology] is valued at $72.62M. LYRA’s [@Biotechnology] market capitalization is $390.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $576.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CKPT’s FA Score shows that 0 FA rating(s) are green whileLYRA’s FA Score has 0 green FA rating(s).

  • CKPT’s FA Score: 0 green, 5 red.
  • LYRA’s FA Score: 0 green, 5 red.
According to our system of comparison, LYRA is a better buy in the long-term than CKPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CKPT’s TA Score shows that 7 TA indicator(s) are bullish while LYRA’s TA Score has 3 bullish TA indicator(s).

  • CKPT’s TA Score: 7 bullish, 2 bearish.
  • LYRA’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, CKPT is a better buy in the short-term than LYRA.

Price Growth

CKPT (@Biotechnology) experienced а +8.24% price change this week, while LYRA (@Biotechnology) price change was +7.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.76%. For the same industry, the average monthly price growth was +4.84%, and the average quarterly price growth was +88.94%.

Reported Earning Dates

CKPT is expected to report earnings on May 15, 2023.

LYRA is expected to report earnings on May 07, 2024.

Industries' Descriptions

@Biotechnology (+4.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CKPT with price predictions.
OPEN
A.I.dvisor published
a Summary for LYRA with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
LYRA($390M) has a higher market cap than CKPT($72.6M). LYRA YTD gains are higher at: 24.618 vs. CKPT (-11.135). CKPT has higher annual earnings (EBITDA): -52.15M vs. LYRA (-65.25M). LYRA has more cash in the bank: 103M vs. CKPT (4.93M). CKPT has less debt than LYRA: CKPT (2.47M) vs LYRA (26.9M). LYRA has higher revenues than CKPT: LYRA (1.56M) vs CKPT (103K).
CKPTLYRACKPT / LYRA
Capitalization72.6M390M19%
EBITDA-52.15M-65.25M80%
Gain YTD-11.13524.618-45%
P/E RatioN/AN/A-
Revenue103K1.56M7%
Total Cash4.93M103M5%
Total Debt2.47M26.9M9%
FUNDAMENTALS RATINGS
CKPT: Fundamental Ratings
CKPT
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CKPTLYRA
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 9 days ago
81%
Declines
ODDS (%)
Bearish Trend 10 days ago
88%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
71%
View a ticker or compare two or three
Ad is loading...
CKPTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
LYRADaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KSRYY10.750.53
+5.19%
Kose Corp
SUNWQ0.04N/A
+2.27%
SUNWORKS
LNNGY63.980.06
+0.09%
Li Ning Company Limited
WRLGF0.52N/A
-0.54%
WEST RED LAKE GOLD MINES Ltd
DSDVY81.38-1.03
-1.25%
DSV A/S American Depositary Receipts - Unsponsored

CKPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, CKPT has been loosely correlated with CYCC. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CKPT jumps, then CYCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CKPT
1D Price
Change %
CKPT100%
-1.69%
CYCC - CKPT
52%
Loosely correlated
+2.08%
CARA - CKPT
45%
Loosely correlated
+19.01%
CYTK - CKPT
42%
Loosely correlated
+0.37%
FATE - CKPT
42%
Loosely correlated
+7.00%
MIRM - CKPT
37%
Loosely correlated
+0.80%
More

LYRA and

Correlation & Price change

A.I.dvisor tells us that LYRA and ARVN have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LYRA and ARVN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYRA
1D Price
Change %
LYRA100%
+6.53%
ARVN - LYRA
26%
Poorly correlated
+0.85%
BCYC - LYRA
25%
Poorly correlated
+0.08%
HLVX - LYRA
25%
Poorly correlated
-1.39%
ADCT - LYRA
25%
Poorly correlated
-3.45%
APLS - LYRA
24%
Poorly correlated
-0.90%
More